MEBIS, Jeroen

Email Alert RSS Feed

Profile

Full Name
MEBIS, Jeroen
Email
jeroen.mebis@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 21-40 of 91 (Search time: 0.005 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
212022Photobiomodulation therapy for the management of chemotherapy-induced alopecia: Preliminary results of a randomized, controlled trialLODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; MEBIS, JeroenJournal ContributionM
22022Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology GroupVergote, I; Van Nieuwenhuysen, E; De Waele, S; Vulsteke, C; Lamot, C; Van den Bulck, H; CLAES, Nele; Graas, MP; DEBROCK, Guy; Spoormans, I; Vuylsteke, P; Honhon, B; Verhoeven, D; De Maeseneer, Daan; Dirix, L; MEBIS, Jeroen; Vroman, P; Denys, H; Mena, CM; Pelgrims, G; Van Steenberghe, M; van Gorp, Toon; Gennigens, CJournal ContributionA1
32022Photobiomodulation Therapy in Management of Cancer Therapy-Induced Side Effects: WALT Position Paper 2022ROBIJNS, Jolien; LODEWIJCKX, Joy; Arany, Praveen; Barasch, Andrei; Jan, Bjordal; Bossi, Paolo; Chilles, Anne; Corby, Patricia; Epstein, Joel; Elad, Sharon; Fekrazad, Reza; Fregnani, Eduardo; Genot, Marie-Thérèse; Ibarra, Ana; Hamblin, Michael; Heiskanen, Vladimir; Hu, Ken; Klastersky, Jean; Lalla, Raj; Latifian, Sofia; Maiya, Arun; MEBIS, Jeroen; Migliorati, Cesar; Milstein, Dan; Murhpy, Barbara; Raber-Durlacher, Judith; Roseboom, Hendrik; Sonis, Stephen; Treister, Nathaniel; Zadik, Yehuda; Bensadoun, René-JeanJournal ContributionA1
42022PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignmentThouvenin, J.; Van Marcke, C.; Decoster, L.; Raicevic, G.; Punie, K.; Vandenbulcke, M.; Salgado, R.; Van Valckenborgh, E.; Maes, B.; Joris, S.; Vander Steichel, D.; Vranken, K.; Jacobs , S.; Dedeurwaerdere, F.; Martens, G.; Devos, H.; Duhoux, F. P.; Rasschaert, M.; Pauwels , P.; Geboes, K.; Collignon, J.; Tejpar, S.; Canon, J-L; Peeters, M.; Rutten, A.; Van de Mooter, T.; Vermeij, J.; Schrijvers, D.; Demey, W.; Lybaert, W.; Van Huysse, J.; MEBIS, Jeroen; Awada, A.; Claes, K. B. M.; Hebrant, A.; Van der Meulen, J.; Delafontaine, B.; Vanden Bempt, I; Maetens, J.; de Hemptinne, M.; Rottey, S.; Aftimos, P.; De Greve, J.Journal ContributionA1
52022Photobiomodulation therapy for the prevention of acute radiation dermatitis in breast cancer patients undergoing hypofractioned whole‐breast irradiation (LABRA trial)ROBIJNS, Jolien; LODEWIJCKX, Joy; Van Bever, Leen; Puts, Sofie; Timmermans, An; Noe, Leen; Vanmechelen, Sofie; Govers, Mieke; Van de Werf, Evelyn; MAES, Annelies; BULENS, Paul; MEBIS, Jeroen; Claes, Stefan; Pannekoeke, LucJournal ContributionA1
62022The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled pilot trial (NEUROLASER trial)LODEWIJCKX, Joy; ROBIJNS, Jolien; CLAES, Marithe; Evens, Stijn; Swinnen, Laura; Lenders, Hilde; Bortels, Sandra; Nassen, Wendy; Hilkens, Ruth; Raymakers, Liesbeth; Snoekx, Sylvana; Hermans, Sylvia; MEBIS, JeroenJournal ContributionA1
72021A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysisBrufsky, A.; Kim, S. B.; Zvirbule, Z.; Eniu, A.; MEBIS, Jeroen; Sohn, J. H.; Wongchenko, M.; Chohan, S.; Amin, R.; Yan, Y.; McNally, V; Miles, D.; Loi, S.Journal ContributionA1
82021Efficacy of olaparib in advanced cancers occurring in patients with germline or somatic tumor mutations in homologous recombination (HR) genes, a Belgian Precision phase II basket studyJoris, S.; Denys, H.; Martin, M.; de Roodenbeke, D. t'Kint; Duhoux, F.; Berchem, G.; Punie, K.; Bols, A.; MEBIS, Jeroen; Canon, J-L.; Decoster, L.; De Greve, J.Journal ContributionM
92021Response to the Comment on "Photobiomodulation therapy for the prevention of acute radiation dermatitis (RD) in head and neck cancer patients (DERMISHEAD trial)" by Baiocchi et alROBIJNS, Jolien; LODEWIJCKX, Joy; Claes, Stefan; Van Bever, Leen; Pannekoeke, Luc; Censabella, Sandrine; Timmermans, An; Noé, Leen; Bussé, Lore; Colson, Dora; Kaminski, Iris; Broux, Victoria; Puts, Sofie; Vanmechelen, Sofie; BULENS, Paul; Govers, Mieke; MAES, Annelies; MEBIS, JeroenJournal ContributionA1
102021Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)ROBIJNS, Jolien; LODEWIJCKX, Joy; Claes, Stefan; Van Bever, Leen; Pannekoeke, Luc; Censabella, Sandrine; Bussé, Lore; Colson, Dora; Kaminski, Iris; Broux, Victoria; Puts, Sofie; Vanmechelen, Sofie; Timmermans, An; Noé, Leen; BULENS, Paul; Govers, Mieke; MAES, Annelies; MEBIS, JeroenJournal ContributionA1
112021Response to the Letter to the editor by Donnelly et al. regarding the article "Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial)"ROBIJNS, Jolien; LODEWIJCKX, Joy; Van Bever, Leen; Pannekoeke, Luc; Censabella, Sandrine; Timmermans, An; Noé, Leen; Govers, Mieke; Bussé, Lore; Colson, Dora; Kaminski, Iris; Broux, Victoria; Puts, Sofie; BULENS, Paul; Vanmechelen, Sofie; MAES, Annelies; MEBIS, Jeroen; Claes, StefanJournal ContributionA1
122021The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: Preliminary results of a randomized, placebo-controlled trialLODEWIJCKX, Joy; ROBIJNS, Jolien; Hermans, S; MEBIS, JeroenJournal ContributionM
132021A digital automated health monitoring system for oncology patients during the COVID-19 pandemic: Practical issues and lessons for the futureROBIJNS, Jolien; LODEWIJCKX, Joy; WIJNEN, Katrien; Snoekx, Sylvana; Hilkens, Ruth; Bortels, Sandra; Lenders, Hilde; Nassen, Wendy; Dewaele, Elien; Luyten, D.; Joosens, Eric; Requilé, Annelies; Verheezen, Yolanda; Wessels, Tim; BULENS, Paul; MEBIS, JeroenJournal ContributionA1
142021The safe use of photobiomodulation therapy in an oncologic settingROBIJNS, Jolien; LODEWIJCKX, Joy; MEBIS, JeroenJournal ContributionM
152021Photobiomodulation therapy can prevent the development of severe acute radiodermatitis in head and neck cancer patients: A multicentric, randomized controlled trialROBIJNS, Jolien; LODEWIJCKX, Joy; MEBIS, JeroenJournal ContributionM
162020Neutropenia management in patients receiving myelosuppressive polychemotherapy for early breast cancer in Belgium: BRONS study resultsCatala, Gaetan; MEBIS, Jeroen; Jerusalem, Guy; Verhoeven, Didier; Awada, Ahmad; Bols, Alain; Somers, Luc; Van Den Broeck, Anke; Duhoux, Francois P; Machiels, Jean-PascalJournal ContributionA1
172020Preliminary results of a multicentric, placebo-controlled clinical trialROBIJNS, Jolien; LODEWIJCKX, Joy; Puts , Sofie; Claes, Stefan; Van Bever, Leen; Busse, Lore; Colson , Dora; Kaminski, Iris; Broux, Victoria; MAES, Annelies; BULENS, Paul; Noe, Leen; Brosens, Marc; Govers, Mieke; Timmermans, An; MEBIS, JeroenJournal ContributionM
182020A Narrative Review on the Use of Photobiomodulation Therapy for the Prevention and Management of Acute Radiodermatitis: Proposed Mechanisms, Current Clinical Outcomes, and Preliminary Guidance for Clinical StudiesROBIJNS, Jolien; LODEWIJCKX, Joy; Bensadoun, Rene-Jean; MEBIS, JeroenJournal ContributionA1
192020Photobiomodulation Therapy for the Management of Chemotherapy-Induced Peripheral Neuropathy: An OverviewLODEWIJCKX, Joy; ROBIJNS, Jolien; Bensadoun, René-Jean; MEBIS, JeroenJournal ContributionA1
202019Quality of life, fatigue, and subjective cognitive functioning immediately and 6 months after adjuvant chemotherapy in breast cancer patientsMEBIS, Jeroen; Censabella, S; Engels, Sofie; Van Marsenille, C.; ORYE, Guy; MARQUETTE, Sophie; Vansteelant, L.; Luyten, D.; MAES, Annelies; Noé, L; BULENS, PaulJournal ContributionM
show all